Nardoci Jeffrey C 4
4 · SOLTA MEDICAL INC · Filed Feb 12, 2013
Insider Transaction Report
Form 4
Nardoci Jeffrey C
Vice President of Marketing
Transactions
- Tax Payment
Common Stock
2013-02-08$2.56/sh−8,776$22,467→ 151,344 total - Exercise/Conversion
Common Stock
2013-02-09+22,958→ 174,302 total - Tax Payment
Common Stock
2013-02-10$2.56/sh−6,285$16,090→ 159,596 total - Exercise/Conversion
Performance Restricted Stock Units
2013-02-08−26,800→ 107,296 totalExp: 2022-02-08→ Common Stock (26,800 underlying) - Exercise/Conversion
Common Stock
2013-02-08+26,800→ 171,006 total - Tax Payment
Common Stock
2013-02-08$2.56/sh−10,946$28,022→ 160,120 total - Tax Payment
Common Stock
2013-02-09$2.56/sh−8,421$21,558→ 165,881 total - Exercise/Conversion
Performance Restricted Stock Units
2013-02-09−22,958→ 84,338 totalExp: 2021-02-09→ Common Stock (22,958 underlying)
Footnotes (3)
- [F1]Each performance right represented a contingent right to receive a share of issuer common stock based on the issuer's stock price performance.
- [F2]All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of Performance RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes.
- [F3]All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes.